Feds Announce Final Order Against Brands Targeted in Last Year’s Crackdown

The CBD companies targeted by last December’s federal crackdown – “Operation CBDeceit” – last week agreed to administrative consent orders with the Federal Trade Commission that bars them from “allegedly illegal conduct” with some having to pay fines.

The ‘illegal conduct’ includes making false health claims about CBD.

“The FTC took action against the six sellers for allegedly making a wide range of scientifically unsupported claims about their ability to treat serious health conditions, including cancer, heart disease, hypertension, Alzheimer’s disease, and others.” – FTC in a press release, Mar. 5, 2021

California-based Reef Industries was ordered to pay an $85,000 fine, according to FTC documents. Steve’s Distributing (aka Steve’s Goods) was fined $75,000; Bionatrol Health was fined $20,000; Epichouse LLC (First Class Herbalist CBD) was fined $30,000; and HempmeCBD was ordered to pay $36,254.

The sixth company, CBD Meds, was not issued a fine but was ordered to notify customers of the FTC order. Each agreement was unanimously approved by the commission.

Last spring, the agency took the rare step of filing a lawsuit against CBD company Whole Leaf Organics over the company’s claims that their products treat cancer and prevents or reduces COVID-19 risk.

In December 2019, the Food and Drug Administration issued five warning letters to companies selling CBD products over the companies’ health claims regarding the cannabinoid.

Exclusive offer from our sponsor:

Get daily news insights in your inbox. Subscribe

Source link

Medical Disclaimer:

The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like
Read More

Q&A with CEO Greg Engel

[ad_1] While rival Canadian cannabis producers plowed massive amounts of capital into cultivation infrastructure, losing billions of dollars…